pentoxifylline has been researched along with Toxemia in 4 studies
Toxemia: A condition produced by the presence of toxins or other harmful substances in the BLOOD.
Excerpt | Relevance | Reference |
---|---|---|
" Thromboxane A2 is the major mediator of the early pulmonary hypertension associated with endotoxemia, but the mechanisms underlying the prolonged hemodynamic disturbances observed in ongoing endotoxemia are not well understood." | 3.69 | Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia. ( Li, JX; Lu, CY; Oliver, JR; Philips, JB, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, JX | 1 |
Oliver, JR | 1 |
Lu, CY | 1 |
Philips, JB | 1 |
Balázs, C | 1 |
Kiss, E | 1 |
Zabel, P | 1 |
Schade, FU | 1 |
Schlaak, M | 1 |
Rumiantsev, ISh | 1 |
Kaznacheeva, IG | 1 |
Abdiadilova, LV | 1 |
Kozlov, VV | 1 |
2 reviews available for pentoxifylline and Toxemia
Article | Year |
---|---|
Immunological aspects of the effect of pentoxifylline (Trental) (a brief review).
Topics: Animals; Cytokines; HIV Infections; Humans; Immune System; In Vitro Techniques; Neoplasms; Pentoxify | 1994 |
Inhibition of endogenous TNF formation by pentoxifylline.
Topics: Animals; Cells, Cultured; Cytokines; Humans; Indomethacin; Kidney Transplantation; Leukopenia; Lipop | 1993 |
2 other studies available for pentoxifylline and Toxemia
Article | Year |
---|---|
Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Endotoxins; Female; Hemodynamics; Humans; Hypertension, Pulmo | 1995 |
[The effect of pathogenetic therapy on the expression of endogenous intoxication in patients with chronic glomerulonephritis].
Topics: Chronic Disease; Cyclophosphamide; Drug Therapy, Combination; Glomerulonephritis; Heparin; Humans; M | 1992 |